Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension
NCT00380068
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
224
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Hypertension
Interventions
DRUG:
Ambrisentan
Sponsor
Gilead Sciences